ID

34602

Descripción

Efficacy of VIldagliptin aS an Add-on Therapy to Metformin Compared to Metformin Up-TitratION in Chinese Patients With Type 2 Diabetes.(VISION); ODM derived from: https://clinicaltrials.gov/show/NCT01541956

Link

https://clinicaltrials.gov/show/NCT01541956

Palabras clave

Versiones (1)
  1. 19/1/19 19/1/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

19 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Type 2 Diabetes NCT01541956

Inglés

Eligibility Type 2 Diabetes NCT01541956

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
chinese t2d patients who are inadequate controlled (6.5 %< hba1c ≤9%) by metformin (≥750mg/d but ≤1000mg/d, ≥12 weeks),
Descripción

ID.1

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 diabetes and secondary diabetes
Descripción

ID.2

Tipo de datos

boolean

acute metabolic diabetic complications within the past 3 months.
Descripción

ID.3

Tipo de datos

boolean

acute infections which may influence glucose level.
Descripción

ID.4

Tipo de datos

boolean

evidence of significant chronic diabetic complications,
Descripción

ID.5

Tipo de datos

boolean

clinically significant renal impairment and hepatic impairment patients, including history of cirrhosis or chronic hepatitis,
Descripción

ID.6

Tipo de datos

boolean

fpg > 270 mg/dl (15 mmol/l)
Descripción

ID.7

Tipo de datos

boolean

any of the following disease within the past 6 months: myocardial infarction (mi); coronary artery bypass surgery or percutaneous coronary intervention; unstable angina or stroke; congestive heart failure (chf)
Descripción

ID.8

Tipo de datos

boolean

other protocol-defined inclusion/exclusion criteria may apply
Descripción

ID.9

Tipo de datos

boolean

Volver a la parte superior de la página

Similar models

Eligibility Type 2 Diabetes NCT01541956

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
chinese t2d patients who are inadequate controlled (6.5 %< hba1c ≤9%) by metformin (≥750mg/d but ≤1000mg/d, ≥12 weeks),
boolean
Item Group
C0680251 (UMLS CUI)
ID.2
Item
type 1 diabetes and secondary diabetes
boolean
ID.3
Item
acute metabolic diabetic complications within the past 3 months.
boolean
ID.4
Item
acute infections which may influence glucose level.
boolean
ID.5
Item
evidence of significant chronic diabetic complications,
boolean
ID.6
Item
clinically significant renal impairment and hepatic impairment patients, including history of cirrhosis or chronic hepatitis,
boolean
ID.7
Item
fpg > 270 mg/dl (15 mmol/l)
boolean
ID.8
Item
any of the following disease within the past 6 months: myocardial infarction (mi); coronary artery bypass surgery or percutaneous coronary intervention; unstable angina or stroke; congestive heart failure (chf)
boolean
ID.9
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial